A detailed history of Baillie Gifford & CO transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 2,383,029 shares of VIR stock, worth $17.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,383,029
Previous 3,921,242 39.23%
Holding current value
$17.6 Million
Previous $34.9 Million 48.86%
% of portfolio
0.01%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$7.26 - $10.7 $11.2 Million - $16.5 Million
-1,538,213 Reduced 39.23%
2,383,029 $17.8 Million
Q2 2024

Jul 25, 2024

SELL
$7.63 - $12.66 $197,029 - $326,919
-25,823 Reduced 0.65%
3,921,242 $34.9 Million
Q1 2024

May 01, 2024

SELL
$8.6 - $11.9 $158,962 - $219,959
-18,484 Reduced 0.47%
3,947,065 $40 Million
Q4 2023

Jan 26, 2024

SELL
$7.76 - $10.29 $46,730 - $61,966
-6,022 Reduced 0.15%
3,965,549 $39.9 Million
Q3 2023

Nov 13, 2023

SELL
$9.14 - $24.62 $108,528 - $292,337
-11,874 Reduced 0.3%
3,971,571 $37.2 Million
Q2 2023

Jul 28, 2023

SELL
$23.2 - $27.29 $59,879 - $70,435
-2,581 Reduced 0.06%
3,983,445 $97.7 Million
Q1 2023

May 03, 2023

BUY
$22.26 - $30.85 $31,720 - $43,961
1,425 Added 0.04%
3,986,026 $92.8 Million
Q4 2022

Jan 24, 2023

BUY
$19.96 - $28.22 $118,642 - $167,739
5,944 Added 0.15%
3,984,601 $101 Million
Q3 2022

Oct 27, 2022

BUY
$18.26 - $31.1 $872,919 - $1.49 Million
47,805 Added 1.22%
3,978,657 $76.7 Million
Q2 2022

Aug 08, 2022

SELL
$19.08 - $26.7 $311,156 - $435,423
-16,308 Reduced 0.41%
3,930,852 $100 Million
Q1 2022

May 05, 2022

BUY
$21.19 - $40.01 $670,854 - $1.27 Million
31,659 Added 0.81%
3,947,160 $102 Million
Q4 2021

Jan 20, 2022

BUY
$30.97 - $54.03 $489,604 - $854,160
15,809 Added 0.41%
3,915,501 $164 Million
Q3 2021

Oct 19, 2021

BUY
$34.9 - $54.54 $1.75 Million - $2.74 Million
50,183 Added 1.3%
3,899,692 $170 Million
Q2 2021

Aug 02, 2021

BUY
$38.75 - $51.0 $1.25 Million - $1.65 Million
32,361 Added 0.85%
3,849,509 $182 Million
Q1 2021

May 06, 2021

BUY
$26.34 - $83.07 $1.9 Million - $6 Million
72,200 Added 1.93%
3,817,148 $196 Million
Q4 2020

Feb 10, 2021

BUY
$25.51 - $43.38 $741,320 - $1.26 Million
29,060 Added 0.78%
3,744,948 $100 Million
Q3 2020

Nov 12, 2020

BUY
$28.28 - $53.6 $7.15 Million - $13.5 Million
252,686 Added 7.3%
3,715,888 $128 Million
Q2 2020

Aug 12, 2020

BUY
$27.89 - $47.86 $93 Million - $160 Million
3,333,333 Added 2566.69%
3,463,202 $142 Million
Q1 2020

May 08, 2020

SELL
$12.04 - $60.2 $4.46 Million - $22.3 Million
-370,131 Reduced 74.03%
129,869 $4.45 Million
Q4 2019

Feb 10, 2020

BUY
$11.83 - $15.85 $5.92 Million - $7.93 Million
500,000 New
500,000 $6.29 Million

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.